THE ETHICAL ISSUES OF PHARMACOGENETIC TESTS
Author(s)
Colak M, Tunceli HD, Pak MD
baskent university, Ankara, Turkey
Presentation Documents
OBJECTIVES: It is possible to verify a genetic disorder of an individual and also to determine if the individual carries the sick gene to future generation in risky pregnancies or not with pharmacogenetic tests and also these tests enable us to do genetic mapping. Pharmacogenetic studies can be considered as “personalized medicine”. At this point ethical issues come up. In this study, the ethical issues of pharmacogenetic tests were evaluated according to medicine students. METHODS: It is a descriptive cross-sectional study. The universe of the study consists of 456 medicine students and the sample consists of 280 randomly selected medicine students. Firstly definitive information about pharmacogenetic tests were given and then 11 ethical dimensions of pharmacogenetic tests were asked by face to face questionnaire design. Data were analyzed with SPSS 21.0 program. Descriptive statistics were used in the analysis. RESULTS: CONCLUSIONS: The possibility of unauthorized individuals taking patients medical records into their possessions, genetic information being commercialized, insurance companies putting pressure on customers to take pharmacogenetics tests and employers putting pressure on employees to take this tests, securing medication safety with pharmaceuticals industry and possibility of the society's genetic map being a potential for a biological attack (bioterrorism) as ethical issues were determined in the study
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PHP154
Topic
Health Service Delivery & Process of Care
Topic Subcategory
Health Care Research, Hospital and Clinical Practices
Disease
Multiple Diseases